MSCs from SLE patients have elevated MAVS, TGF-β, ROS, telomerase activity, DNA damage, and increase expression of senescence associated genes that block the cell cycle (Nie et al., 2010; Gao et al., 2017). The gene discussed is MAVS; the disease is systemic lupus erythematosus.